BR vs TRDA · P/E 16, rev $6.89B vs P/E 12, rev $210.8M
Broadridge Financial Solutions Inc (BR) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
BR currently screens at market cap $17.65B and trailing P/E 16.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the BR and TRDA stock pages for the full models.
Not investment advice.